What is it about?
This study sought to investigate the effects of omega (ω)-3 polyunsaturated fatty acid (PUFA) supplementation on the lipid profiles and glucose (GLU) levels of overweight (OW) schoolchildren with metabolic syndrome (MS), during one month time treatment.
Featured Image
Why is it important?
Both sexes of Overweight schoolchildren with Metabolic Syndrome who received daily supplementation with 2.4 g of ω-3 fatty acids for 1 month displayed improved lipid profiles, reduced fasting glucose levels and reduced blood pressure.
Perspectives
I hope this article helps other clinical researchers to manage the obesity in schoolchildren as we examined the intervention with ω-3 fatty acid supplementation successfully improved the lipid profiles and reduced the GLU levels and BP of OW children with MS but did not alter their weights.
Professor Salvador García-López
Universidad Autonoma Metropolitana
Read the Original
This page is a summary of: One month of omega-3 fatty acid supplementation improves lipid profiles, glucose levels and blood pressure in overweight schoolchildren with metabolic syndrome, Journal of Pediatric Endocrinology and Metabolism, January 2016, De Gruyter,
DOI: 10.1515/jpem-2015-0324.
You can read the full text:
Contributors
The following have contributed to this page
